ALLO EBITDA Growth
Allogene Therapeutics Inc · EBITDA Growth
ALLO EBITDA Growth
Year-over-year change vs the same period a year earlier
Latest reported31.67%period ending
ALLO TTM EBITDA YoY % (7.05% → 31.67%)
Year-over-year change
High-resolution chart · PNG
ALLO ebitda growth history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Growth |
|---|---|
| 31.6704% | |
| 32.706% | |
| 27.0726% | |
| 22.4584% | |
| 11.1827% | |
| 9.7785% | |
| 18.6788% | |
| 20.7559% | |
| 26.7521% | |
| 21.9818% | |
| 6.0062% | |
| -8.5334% | |
| -16.805% | |
| -16.1269% | |
| -29.0188% | |
| -26.1355% | |
| -29.9897% | |
| -33.596% | |
| -1.6906% | |
| 2.8301% | |
| 1.7141% | |
| -2.2556% | |
| -25.3338% | |
| -47.5411% | |
| -52.9825% | |
| 11.0726% | |
| 6.4208% | |
| 7.0459% |